4.7 Article

Solid-phase synthesis of imprinted nanoparticles as artificial antibodies against the C-terminus of the cannabinoid CB1 receptor: exploring a viable alternative for bioanalysis

期刊

MICROCHIMICA ACTA
卷 188, 期 11, 页码 -

出版社

SPRINGER WIEN
DOI: 10.1007/s00604-021-05029-z

关键词

Artificial antibody; Epitope imprinting; GPCR; CB1 receptor; Molecularly imprinted nanoparticles; Bioanalysis

资金

  1. CRUE-CSIC
  2. Springer Nature
  3. Spanish Ministry of Science, Innovation and Universities [CTQ2017-85686-R]
  4. Basque Government (Research Groups of the Basque University System) [IT 1186-19]

向作者/读者索取更多资源

This study describes the production of artificial anti-CB1 antibodies in nanoparticle format using a solid-phase imprinting approach. By selecting a linear C-terminus sequence of the receptor as a template, the artificial antibody showed affinity and selectivity towards the target protein through dot blot and Western blot experiments. The developed molecularly imprinted materials pave the way for novel imprinted nanomaterials for other proteins within the superfamily of G-protein-coupled receptors (GPCR).
The production of artificial anti-CB1 antibodies in nanoparticle format is described using the solid-phase imprinting approach. Instead of whole protein imprinting, a linear C-terminus sequence of the receptor comprising 15 amino acids (458-KVTMSVSTDTSAEAL-472) has been used as template, in accordance with the epitope imprinting approach. This sequence is located intracellularly, and it is involved in coupling to G(i/o) proteins, being responsible for CB1 receptor desensitisation and internalisation. Developed molecularly imprinted materials were found to be in the nanometre scale, with a particle size of 126.4 +/- 10.5 nm at pH 3 (25 oC) and spherical shape. It was also observed that the size was sensible to temperature changes being reduced to 106.3 +/- 15.2 nm at 35 degrees C. Lower critical solution temperature of this polymer was found to be approximate to 33.4 degrees C. The affinity and selectivity of the artificial antibody were assessed through dot blot and Western blot experiments. For the latter, recombinant fusion proteins GST-CB1(414-472) and GST-CB1(414-442) were produced to work respectively as target and negative control proteins. The control protein did not carry the target epitope for being devoid of last 30 amino acids at the C-terminus. The results demonstrated that the anti-CB1 material recognised selectively the target protein, thanks to the presence of the 15-amino acid sequence selected as epitope, which revealed that binding occurred at the C-terminus of the receptor itself. The methodology presented may pave the way for the development of novel imprinted nanomaterials for other proteins included in the superfamily of the G-protein-coupled receptors (GPCR).

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据